Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorYanyalı, A.
dc.contributor.authorÇelik, G.
dc.contributor.authorDinçyıldız, A.
dc.contributor.authorHorozoğlu, Fatih
dc.contributor.authorNohutçu, A.F.
dc.date.accessioned2022-05-11T14:35:46Z
dc.date.available2022-05-11T14:35:46Z
dc.date.issued2012
dc.identifier.issn16725123
dc.identifier.urihttps://doi.org/10.3969/j.issn.1672-5123.2012.07.03
dc.identifier.urihttps://hdl.handle.net/20.500.11776/8209
dc.description.abstractAIM: To report the effectiveness and safety of primary 23-Gauge (G) vitreoretinal surgery for rhegmatogenous retinal detachment (RRD). METHODS: In this retrospective study, 49 eyes of 49 consecutive patients who underwent primary 23-G transconjunctival sutureless vitrectomy (TSV) for RRD between January 2007 and July 2009 at our institution were evaluated. RESULTS: Mean follow-up time was 8.9±7.7 months. Retinal reattachment was achieved with a single operation in 47(95.9%) of 49 eyes. In two eyes (4.1%), retinal redetachment due to new breaks was successfully treated with reoperation using the 23-G TSV system. Mean logMAR visual acuity was 2.01±0.47 preoperatively and 1.3±0.5 postoperatively (P<0.001, Paired t-test). Mean preoperative intraocular pressure (IOP) was 14.1±2.8mmHg. Mean postoperative IOP was 12.3±3.6mmHg at 1 day, 13.1±2.1mmHg at 1 week, 14.3±2.2mmHg at 1 month. Iatrogenic peripheral retinal break was observed in 1 eye (2.0%) intraoperatively. No sutures were required to close the scleral or conjunctival openings, and no eyes required convertion of surgery to 20-G vitrectomy. CONCLUSION: Primary 23-G TSV system was observed to be effective and safe in the treatment of RRD.en_US
dc.language.isoengen_US
dc.identifier.doi10.3969/j.issn.1672-5123.2012.07.03
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject23-gauge transconjunctival sutureless vitrectomyen_US
dc.subjectRhegmatogenous retinal detachmenten_US
dc.subjectantiglaucoma agenten_US
dc.subjectadulten_US
dc.subjectarticleen_US
dc.subjectcataracten_US
dc.subjectclinical articleen_US
dc.subjectclinical effectivenessen_US
dc.subjectdisease courseen_US
dc.subjectepiretinal membraneen_US
dc.subjectfemaleen_US
dc.subjectfollow upen_US
dc.subjectglaucomaen_US
dc.subjecthumanen_US
dc.subjecthypotony maculopathyen_US
dc.subjectintraocular pressureen_US
dc.subjectintraoperative perioden_US
dc.subjectlaser coagulationen_US
dc.subjectmaleen_US
dc.subjectpatient safetyen_US
dc.subjectpostoperative complicationen_US
dc.subjectpostoperative perioden_US
dc.subjectpreoperative perioden_US
dc.subjectprimary 23 gauge transconjunctival sutureless vitrectomyen_US
dc.subjectredetachmenten_US
dc.subjectreoperationen_US
dc.subjectretina detachmenten_US
dc.subjectretina hemorrhageen_US
dc.subjectretina tearen_US
dc.subjectretrospective studyen_US
dc.subjectsilicone oil droplet in anterior chamberen_US
dc.subjectvisual acuityen_US
dc.subjectvitreoretinal surgeryen_US
dc.titlePrimary 23-gauge vitreoretinal surgery for rhegmatogenous retinal detachmenten_US
dc.typearticleen_US
dc.relation.ispartofInternational Eye Scienceen_US
dc.departmentFakülteler, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Göz Hastalıkları Ana Bilim Dalıen_US
dc.identifier.volume12en_US
dc.identifier.issue7en_US
dc.identifier.startpage1231en_US
dc.identifier.endpage1236en_US
dc.institutionauthorHorozoğlu, Fatih
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.authorscopusid6602766456
dc.authorscopusid55318646300
dc.authorscopusid55318694600
dc.authorscopusid9733109900
dc.authorscopusid9734022700
dc.identifier.scopus2-s2.0-84864111434en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster